Inebilizumab for Treatment of IgG4-Related Disease
Article Details
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
Authors (24)
John H. Stone
Division of Rheumatology, Inflammation, and Immunology, Massachusetts General Hospital, Boston
Arezou Khosroshahi
Division of Rheumatology, Emory University School of Medicine, Atlanta
Wen Zhang
Emanuel Della Torre
Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan
Kazuichi Okazaki
Kansai Medical University Kori Hospital, Osaka, Japan
Yoshiya Tanaka
Department of Molecular Targeted Therapeutics, University of Occupational and Environmental Health, Kitakyushu, Japan
J. Matthias Löhr
Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm
Nicolas Schleinitz
Department of Internal Medicine, Aix-Marseille Université, Assistance Publique–Hôpitaux de Marseille, Hôpital de la Timone, Marseille, France
Lingli Dong
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Hisanori Umehara
Marco Lanzillotta
Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan
Zachary S. Wallace
Mikael Ebbo
Department of Internal Medicine, Aix-Marseille Université, Assistance Publique–Hôpitaux de Marseille, Hôpital de la Timone, Marseille, France
George J. Webster
Department of Gastroenterology, University College London Hospitals, London
Fernando Martinez Valle
Internal Medicine Department, Vall d’Hebron Hospital, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona
Manu K. Nayar
Hepato-Pancreato-Biliary Unit, Freeman Hospital, Newcastle upon Tyne, United Kingdom
Cory A. Perugino
Division of Rheumatology, Inflammation, and Immunity, Mass General Brigham, Boston
Vinciane Rebours
Pancreatology and Digestive Oncology Department, Beaujon Hospital, Université Paris Cité, Clichy, France
Xinxin Dong
Amgen, Thousand Oaks, CA
Yanping Wu
Qing Li
Nishi Rampal
Amgen, Thousand Oaks, CA
Daniel Cimbora
Amgen, Thousand Oaks, CA
Emma L. Culver